Schiff

Melatonin Plus

C-
N+ Score67
Sleep & RecoveryServing: 1 Tablet(s)Type: Other Combinations

Schiff Melatonin Plus is a sleep and recovery supplement featuring 3 active ingredients. Each serving provides 3 mg of Melatonin, 10 mg of Vitamin B6, and 25 mg of L-Theanine. The Vitamin B6 is present at a clinically studied dose, which research suggests may support nervous system function. However, the L-Theanine dosage of 25 mg is significantly lower than amounts typically associated with clinical efficacy for relaxation or sleep support. This product has an N+ Score of 67, earning a C- grade, indicating an average formulation with some underdosed components. The label transparency is 100%, but ingredient adequacy is rated at 50% due to the L-Theanine. This supplement may be considered by individuals seeking basic melatonin support with an added clinical dose of Vitamin B6.

About This Product

Melatonin Plus by Schiff is a sleep & recovery supplement containing 3 active ingredients. It has earned an N+ Score of 67/100 (Grade C-).

Notable clinical-dose ingredients include Vitamin B6.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity83/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • No major weaknesses identified

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Vitamin B610.000 mgOptimal
Melatonin3.000 mgN/A
L-Theanine25.000 mgUnder

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.